Table 1 Baseline characteristic of patients with ICG-R15 ≥ 10% or ICG-R15 < 10%
Before propensity matching | After propensity matching | |||||
|---|---|---|---|---|---|---|
≥ 10% (n = 97) | < 10% (n = 203) | p-value | ≥ 10% (n = 58) | < 10% (n = 58) | p-value | |
Age (Y) | 55.57 ± 11.12 | 51.68 ± 12.24 | 0.009* | 55.07 ± 11.65 | 54.09 ± 12.03 | 0.656 |
Sex (male, %) | 72 (74.23%) | 167 (82.27%) | 0.106 | 45 (77.59%) | 52 (89.66%) | 0.079 |
BMI | 23.39 ± 3.24 | 22.93 ± 3.07 | 0.232 | 23.53 ± 3.31 | 22.55 ± 3.39 | 0.117 |
HGB (g/L) | 128.52 ± 25.66 | 138.49 ± 23.92 | 0.001* | 131.76 ± 28.53 | 134.57 ± 25.56 | 0.578 |
WBC(× 109 /L) | 4.96 ± 2.54 | 5.72 ± 1.86 | 0.005* | 5.37 ± 2.81 | 5.41 ± 2.03 | 0.928 |
PLT (× 109 /L) | 112.62 ± 72.50 | 153.88 ± 76.22 | < 0.001* | 122.19 ± 60.93 | 138.29 ± 77.14 | 0.215 |
HBV (positive, %) | 77 (79.38%) | 145 (71.43%) | 0.241 | 48 (82.76%) | 41 (70.69%) | 0.125 |
Tb (μmol/L) | 23.58 ± 12.90 | 15.88 ± 7.81 | < 0.001* | 18.80 ± 9.44 | 19.47 ± 10.32 | 0.716 |
AST (median IU/L) | 56.0 (39.0–74.0) | 42.0 (27.0–62.0) | < 0.001* | 49.00 (37.75–71.75) | 52.50 (32.50–71.05) | 0.722 |
ALT (median IU/L) | 45.0 (27.0–71.0) | 39.0 (22.0–60.0) | 0.030* | 41.50 (27.00–55.25) | 44.50 (21.75–84.25) | 0.647 |
ALB (g/L) | 36.8 ± 4.85 | 41.12 ± 4.38 | < 0.001* | 38.25 ± 4.61 | 38.15 ± 3.99 | 0.897 |
PT(s) | 12.28 ± 1.12 | 12.59 ± 1.49 | 0.071 | 12.64 ± 1.40 | 12.57 ± 1.11 | 0.753 |
TV (mL) | 78.9 (22.49–386.29) | 130.(45.99–405.99) | 0.137 | 88.86 (25.25–451.53) | 156 (81.04–611.76) | 0.107 |
RLV (mL) | 1152.65 ± 358.80 | 1121.30 ± 268.05 | 0.398 | 1128.72 ± 292.35 | 1122.33 ± 326.21 | 0.912 |
SV (mL) | 471.57 ± 282.31 | 284.12 ± 180.39 | < 0.001* | 414.41 ± 210.77 | 324.82 ± 206.34 | 0.023* |
BSA | 1.66 (1.55–1.75) | 1.65 (1.53–1.77) | 0.797 | 1.67 (1.58–1.76) | 1.63 (1.52–1.77) | 0.344 |
SNLV | 703.85 ± 215.92 | 673.60 ± 140.22 | 0.147 | 689.79 ± 167.03 | 676.81 ± 166.46 | 0.805 |
SNLR | 0.44 ± 0.29 | 0.26 ± 0.16 | < 0.001* | 0.38 ± 0.22 | 0.30 ± 0.18 | 0.029* |